MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received

MediciNova Receives Notice of Allowance for New Patent Covering MN-……– and MN-……— ...

12:00am, Monday, 07'th Oct 2019

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China

11:00pm, Monday, 30'th Sep 2019

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received

MediciNova to Present at the Ladenburg Thalmann —…–9 Healthcare Conference in New York

12:00am, Wednesday, 11'th Sep 2019

MediciNova: Leading The Pack In An MS Subtype

12:00am, Tuesday, 20'th Aug 2019

MediciNova files for $200M mixed shelf

12:00am, Saturday, 10'th Aug 2019

28 Healthcare Stocks Moving In Today's Pre-Market Session

12:00am, Friday, 02'nd Aug 2019

MediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in Japan

12:00am, Wednesday, 31'st Jul 2019

MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND in Perth, Australia

12:00am, Tuesday, 30'th Jul 2019

MediciNova Announces MN-–66 (ibudilast) ALS Abstract Accepted for Presentation at the ...

12:00am, Monday, 29'th Jul 2019

28 Healthcare Stocks Moving In Today's Pre-Market Session

12:00am, Friday, 26'th Jul 2019

40 Biggest Movers From Friday

12:00am, Monday, 15'th Jul 2019

Medicinova Stock News

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of NAFLD and NASH in Japan

46 Biggest Movers From Friday

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary Fibrosis in Japan

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary Fibrosis in Japan

MediciNova Receives Notice of Allowance for New Patent Covering MN-……– and MN-……— ...

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China

MediciNova to Present at the Ladenburg Thalmann —…–9 Healthcare Conference in New York

MediciNova: Leading The Pack In An MS Subtype

MediciNova files for $200M mixed shelf

28 Healthcare Stocks Moving In Today's Pre-Market Session

MediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in Japan

MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND in Perth, Australia

MediciNova Announces MN-–66 (ibudilast) ALS Abstract Accepted for Presentation at the ...

28 Healthcare Stocks Moving In Today's Pre-Market Session

40 Biggest Movers From Friday

Top Fintech Company